Page 1 of Clinical Trials for FLOVENT 250, 105 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Last Updated: May 10, 2012
Condition(s): Asthma
2
Recruiting
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Last Updated: May 10, 2012
Condition(s): Asthma
3
Not yet recruiting
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
Last Updated: February 16, 2012
Condition(s): Asthma; Atopy
4
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
Last Updated: November 10, 2011
Condition(s): Asthma
5
Completed
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Last Updated: August 24, 2010
Condition(s): Asthma
6
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
Last Updated: May 5, 2011
Condition(s): Asthma
7
Completed
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
Last Updated: June 8, 2011
Condition(s): Asthma
8
Completed
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: January 19, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
9
Completed
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease
Last Updated: April 5, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
10
Completed
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: April 19, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
11
Not yet recruiting
Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
Last Updated: August 8, 2008
Condition(s): COPD
12
Completed
The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
Last Updated: January 18, 2012
Condition(s): COPD
13
Completed
Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?
Last Updated: October 20, 2009
Condition(s): Mild Asthma
14
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
15
Completed
Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: September 15, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
16
Completed
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
Last Updated: November 23, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
17
Completed
Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients
Last Updated: June 8, 2011
Condition(s): Asthma
18
Completed
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
Last Updated: March 17, 2011
Condition(s): Asthma
19
Active, not recruiting
Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange
Last Updated: July 13, 2011
Condition(s): COPD
20
Completed
Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139AM1)(COMPLETED)
Last Updated: October 26, 2010
Condition(s): Asthma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=FLOVENT+250

Page 1 of Clinical Trials for FLOVENT 250, 105 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About